Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Engeli

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Handbook of Experimental Pharmacology|January 18, 2012
Central and peripheral cannabinoid receptors as therapeutic targets in the control of food intake and body weightStefan Engeli
Contributions to Nephrology|August 25, 2006
Role of the renin-angiotensin- aldosterone system in the metabolic syndromeStefan Engeli
Obesity Facts|January 8, 2010
Peripheral metabolic effects of endocannabinoids and cannabinoid receptor blockadeStefan Engeli
Therapeutic Advances in Endocrinology and Metabolism|November 14, 2012
The clinical pharmacology of obesityStefan Engeli
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 21, 2006
Does salt restriction change brown adipose tissue thermogenesis?Stefan Engeli
Journal of the American Society of Hypertension : JASH|July 6, 2015
Cardiovascular risk factors in severely obese adolescentsStefan Engeli
American Journal of Physiology. Heart and Circulatory Physiology|October 13, 2005
Is there a pathophysiological role for perivascular adipocytes?Stefan Engeli
Clinical Cornerstone|January 9, 2007
The endocannabinoid system: body weight and metabolic regulationStefan Engeli, Jens Jordan
Journal of Hypertension|May 11, 2012
Obesity, hypertension, and cardiovascular health: is there anything poor Cassandra tries to tell us?Jens Jordan, Stefan Engeli
Current Opinion in Nephrology and Hypertension|June 11, 2014
Blood pressure effects of glucagon-like peptide 1 analogues and sodium glucose transporter 2 inhibitorsStefan Engeli, Jens Jordan
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Handbook of Experimental Pharmacology|January 18, 2012
Central and peripheral cannabinoid receptors as therapeutic targets in the control of food intake and body weightStefan Engeli
Contributions to Nephrology|August 25, 2006
Role of the renin-angiotensin- aldosterone system in the metabolic syndromeStefan Engeli
Obesity Facts|January 8, 2010
Peripheral metabolic effects of endocannabinoids and cannabinoid receptor blockadeStefan Engeli
Therapeutic Advances in Endocrinology and Metabolism|November 14, 2012
The clinical pharmacology of obesityStefan Engeli
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 21, 2006
Does salt restriction change brown adipose tissue thermogenesis?Stefan Engeli
Journal of the American Society of Hypertension : JASH|July 6, 2015
Cardiovascular risk factors in severely obese adolescentsStefan Engeli
American Journal of Physiology. Heart and Circulatory Physiology|October 13, 2005
Is there a pathophysiological role for perivascular adipocytes?Stefan Engeli
Clinical Cornerstone|January 9, 2007
The endocannabinoid system: body weight and metabolic regulationStefan Engeli, Jens Jordan
Journal of Hypertension|May 11, 2012
Obesity, hypertension, and cardiovascular health: is there anything poor Cassandra tries to tell us?Jens Jordan, Stefan Engeli
Current Opinion in Nephrology and Hypertension|June 11, 2014
Blood pressure effects of glucagon-like peptide 1 analogues and sodium glucose transporter 2 inhibitorsStefan Engeli, Jens Jordan
Pageof 14